Methscopolamine / phenylephrine Pregnancy and Breastfeeding Warnings
Brand names: AlleRx Dose Pack PE (AM Dose), Extendryl PEM
Methscopolamine / phenylephrine Pregnancy Warnings
Methscopolamine-phenylephrine has been assigned to pregnancy category C by the FDA. Animal studies have not been reported. There are no controlled data in human pregnancy. Methscopolamine-phenylephrine is only recommended for use during pregnancy when benefit outweighs risk.
Methscopolamine / phenylephrine Breastfeeding Warnings
There are no data on the excretion of methscopolamine-phenylephrine into human milk. The effects in the nursing infant are unknown. The manufacturer recommends that caution be used when administering methscopolamine-phenylephrine to nursing women.
References for pregnancy information
- (2008) "Product Information. Extendryl PEM (methscopolamine-phenylephrine)." Auriga Laboratories Inc
References for breastfeeding information
- (2008) "Product Information. Extendryl PEM (methscopolamine-phenylephrine)." Auriga Laboratories Inc
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.